GGrantIndex
← Search

TARGETING N-MYC WITH SELECTIVE AURORA KINASE A DEGRADERS FOR NEUROBLASTOMA THERAPY

$1,476,770FY2021Defense Health AgencyDOD

Regents Of The University Of Minnesota

Investigators

View source on USAspending →
TARGETING N-MYC WITH SELECTIVE AURORA KINASE A DEGRADERS FOR NEUROBLASTOMA THERAPY · GrantIndex